TriSalus Life SciencesTLSI
那斯達克 · USD
7.50
+0.25
(+3.45%)
收盤 12/12 04:58 (UTC+8)
12/12 04:58 (UTC+8)
TriSalus Life SciencesTLSI
7.50
+0.25
(+3.45%)
財務數據
損益表
- -
- 0.05
- 0.06
- 0.06
- 0.07
- 0.07
- 0.08
- 0.09
- 0.11
- 0.12
- -
- -
- 10.15
- 12.86
- 14.05
- -0.20
- 12.41
- 10.97
- 22.32
- 3.15
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 11,566 | 11,213 | 9,167 | 8,261 | 7,349 | 7,364 | 6,457 | 5,721 | 5,194 | - |
營業成本 | 1,906 | 1,802 | 1,495 | 1,216 | 1,004 | 912 | 971 | 582 | 589 | - |
營業毛利 | 9,660 | 9,411 | 7,672 | 7,045 | 6,345 | 6,452 | 5,486 | 5,139 | 4,605 | - |
營業費用 | 18,674 | 16,743 | 15,001 | 14,625 | 15,084 | 14,639 | - | 19,062 | 23,082 | 1,430 |
研發費用 | 5,176 | 3,923 | 3,296 | 2,959 | 4,219 | 4,679 | 5,857 | 7,444 | 9,367 | - |
推銷及管理費用 | 13,498 | 12,820 | 11,705 | 11,666 | 10,865 | 9,960 | 11,314 | 11,618 | 13,715 | 1,430 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -9,014 | -7,332 | -7,329 | -7,580 | -8,739 | -8,187 | -11,685 | -13,923 | -18,477 | -1,430 |
其他收入及費用 | -332 | 464 | -1,832 | -1,461 | 7,479 | 4,726 | -1,528 | -22,725 | 17,176 | 478 |
利息費用 | 1,460 | 1,423 | 1,209 | 1,068 | 1,142 | 877 | 3 | 3 | 4 | - |
稅前純益 | -10,806 | -8,291 | -10,370 | -10,109 | -2,402 | -4,338 | -13,216 | -35,313 | -1,287 | -952 |
所得稅 | 5 | -3 | 5 | -1 | -3 | 7 | 3 | 1 | - | 43 |
稅後純益 | -10,811 | -8,288 | -10,375 | -10,108 | -2,399 | -4,345 | -13,219 | -35,314 | -1,287 | -995 |
基本每股稅後盈餘(元) | -0.96 | -0.27 | -0.39 | -0.40 | -0.12 | -0.21 | -0.60 | -1.56 | -0.14 | -35.84 |
稀釋每股稅後盈餘(元) | -1.07 | -0.26 | -0.39 | -0.40 | -0.10 | -0.21 | -0.60 | -1.05 | 54.07 | -59.22 |
基本平均股數(千股) | 43057.00 | 32899.00 | 28527.00 | 27551.00 | 26501.00 | 23903.00 | 23323.00 | 23231.00 | 13173.00 | 446.00 |
稀釋平均股數(千股) | 43057.00 | 32899.00 | 28527.00 | 27551.00 | 26501.00 | 23903.00 | 23323.00 | 23231.00 | 13173.00 | 446.00 |
還原基本每股稅後盈餘(元) | -0.96 | -0.27 | -0.39 | -0.40 | -0.12 | -0.21 | -0.60 | -1.56 | -0.14 | -35.84 |
還原稀釋每股稅後盈餘(元) | -1.07 | -0.26 | -0.39 | -0.40 | -0.10 | -0.21 | -0.60 | -1.05 | 54.07 | -59.22 |
還原基本平均股數(千股) | 43,057 | 32,899 | 28,527 | 27,551 | 26,501 | 23,903 | 23,323 | 23,231 | 13,173 | 446 |
還原稀釋平均股數(千股) | 43,057 | 32,899 | 28,527 | 27,551 | 26,501 | 23,903 | 23,323 | 23,231 | 13,173 | 446 |
EBITDA(千元) | -8,908 | -6,446 | -8,754 | -8,670 | -911 | -2,987 | -13,025 | -35,098 | -1,117 | -952 |